Connection
Sylvie Kandel to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications Sylvie Kandel has written about Cytochrome P-450 CYP3A Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.113 |
|
|
|
-
Kandel SE, Lampe JN. Inhibition of CYP3A7 DHEA-S Oxidation by Lopinavir and Ritonavir: An Alternative Mechanism for Adrenal Impairment in HIV Antiretroviral-Treated Neonates. Chem Res Toxicol. 2021 04 19; 34(4):1150-1160.
Score: 0.706
-
Work HM, Kandel SE, Lampe JN. Comparison of the CYP3A Selective Inhibitors CYP3cide, Clobetasol, and Azamulin for Their Potential to Distinguish CYP3A7 Activity in the Presence of CYP3A4/5. Drug Metab Dispos. 2024 Oct 16; 52(11):1224-1233.
Score: 0.225
-
Work HM, Kandel SE, Lampe JN. Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening. Sci Rep. 2021 09 30; 11(1):19443.
Score: 0.182